In the B16.F10 murine melanoma model, combined treatment of tumors using IL-2 encoding plasmid (pIL-2) and IL-12 encoding plasmid (pIL-12) induced significant tumor growth delay and 71% complete tumor regression [47]. The gene discussed is IL2; the disease is neoplasm.